AlphaFold predicted structure
C6 · P13671

Mean pLDDT
79.6/ 100
Confident
934 residues
Confidence breakdown
- Very high(≥ 90)13%
- Confident(70–90)71%
- Low(50–70)12%
- Very low(< 50)5%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
complement C6
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalImmunodeficiency due to a late component of complements deficiency
complement deficiency
immunodeficiency due to a late component of complement deficiency
hereditary disease
male reproductive organ cancer
benign neoplasm of brain
central nervous system neoplasm
cardiomyopathy
macular degeneration
benign neoplasm of adrenal gland
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Complement component C6
Component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade, which inserts into a target cell membrane and forms a pore, leading to target cell membrane rupture and cell lysis (PubMed:22267737, PubMed:22832194, PubMed:26841837, PubMed:27052168, PubMed:30552328). The MAC is initiated by proteolytic cleavage of C5 into complement C5b in response to the classical, alternative, lectin and GZMK complement pathways (PubMed:30552328, PubMed:39914456, PubMed:39814882). The complement pathways consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:30552328). Together with component C5b, involved in MAC complex assembly: complement C5b and C6 associate with the outer leaflet of target cell membrane, reducing the energy for membrane bending (PubMed:30552328, PubMed:32569291)
C6 · P13671

Mean pLDDT
79.6/ 100
Confident
934 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0